Annual CFF
$151.43 M
-$58.09 M-27.73%
December 31, 2022
Summary
- As of February 10, 2025, KDNY annual cash flow from financing activities is $151.43 million, with the most recent change of -$58.09 million (-27.73%) on December 31, 2022.
- During the last 3 years, KDNY annual CFF has risen by +$125.75 million (+489.55%).
Performance
KDNY Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFF
$2.01 M
-$19.25 M-90.54%
June 30, 2023
Summary
- As of February 10, 2025, KDNY quarterly cash flow from financing activities is $2.01 million, with the most recent change of -$19.25 million (-90.54%) on June 30, 2023.
- Over the past year, KDNY quarterly CFF has dropped by -$105.13 million (-98.12%).
Performance
KDNY Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFF
$65.81 M
-$105.13 M-61.50%
June 30, 2023
Summary
- As of February 10, 2025, KDNY TTM cash flow from financing activities is $65.81 million, with the most recent change of -$105.13 million (-61.50%) on June 30, 2023.
- Over the past year, KDNY TTM CFF has dropped by -$216.96 million (-76.73%).
Performance
KDNY TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
KDNY Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -27.7% | -98.1% | -76.7% |
| 3 y3 years | +489.6% | +10000.0% | +355.4% |
| 5 y5 years | +489.6% | - | - |
KDNY Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -27.7% | at low | -98.8% | -12.4% | -78.2% | at low |
| 5 y | 5-year | -27.7% | -83.0% | -98.8% | -100.9% | -78.2% | -78.0% |
| alltime | all time | -27.7% | -83.0% | -98.8% | -100.9% | -78.2% | -78.0% |
Chinook Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | $2.01 M(-90.5%) | $65.81 M(-61.5%) |
| Mar 2023 | - | $21.27 M(-10.2%) | $170.94 M(+12.9%) |
| Dec 2022 | $151.43 M(-27.7%) | $23.69 M(+25.8%) | $151.43 M(-49.7%) |
| Sep 2022 | - | $18.83 M(-82.4%) | $301.34 M(+6.6%) |
| Jun 2022 | - | $107.14 M(+5977.2%) | $282.77 M(+34.2%) |
| Mar 2022 | - | $1.76 M(-99.0%) | $210.71 M(+0.6%) |
| Dec 2021 | $209.52 M | $173.61 M(>+9900.0%) | $209.52 M(+43.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $259.00 K(-99.3%) | $145.76 M(+0.2%) |
| Jun 2021 | - | $35.08 M(+5948.1%) | $145.50 M(+31.8%) |
| Mar 2021 | - | $580.00 K(-99.5%) | $110.41 M(-11.2%) |
| Dec 2020 | $124.29 M(+383.9%) | $109.84 M(>+9900.0%) | $124.29 M(+760.2%) |
| Sep 2020 | - | $0.00(-100.0%) | $14.45 M(0.0%) |
| Jun 2020 | - | -$18.00 K(-100.1%) | $14.45 M(-0.1%) |
| Mar 2020 | - | $14.47 M | $14.47 M |
| Dec 2019 | $25.69 M | - | - |
FAQ
- What is Chinook Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Chinook Therapeutics?
- What is Chinook Therapeutics annual CFF year-on-year change?
- What is Chinook Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Chinook Therapeutics?
- What is Chinook Therapeutics quarterly CFF year-on-year change?
- What is Chinook Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Chinook Therapeutics?
- What is Chinook Therapeutics TTM CFF year-on-year change?
What is Chinook Therapeutics annual cash flow from financing activities?
The current annual CFF of KDNY is $151.43 M
What is the all time high annual CFF for Chinook Therapeutics?
Chinook Therapeutics all-time high annual cash flow from financing activities is $209.52 M
What is Chinook Therapeutics annual CFF year-on-year change?
Over the past year, KDNY annual cash flow from financing activities has changed by -$58.09 M (-27.73%)
What is Chinook Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of KDNY is $2.01 M
What is the all time high quarterly CFF for Chinook Therapeutics?
Chinook Therapeutics all-time high quarterly cash flow from financing activities is $173.61 M
What is Chinook Therapeutics quarterly CFF year-on-year change?
Over the past year, KDNY quarterly cash flow from financing activities has changed by -$105.13 M (-98.12%)
What is Chinook Therapeutics TTM cash flow from financing activities?
The current TTM CFF of KDNY is $65.81 M
What is the all time high TTM CFF for Chinook Therapeutics?
Chinook Therapeutics all-time high TTM cash flow from financing activities is $301.34 M
What is Chinook Therapeutics TTM CFF year-on-year change?
Over the past year, KDNY TTM cash flow from financing activities has changed by -$216.96 M (-76.73%)